SuperworthEton Pharmaceuticals EPS ETON
Diluted earnings per share by quarter and over the last twelve months, from 2017.
- Last 12 months, to Jun 30, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- $0.35
- Fiscal year 2021
- −$0.09
Eton Pharmaceuticals' twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was $0.35.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2021 | −$0.09 | n/a |
| FY2020 | −$1.36 | n/a |
| FY2019 | −$1.03 | n/a |
| FY2018 | −$4.73 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.35 | n/a | n/a | |
| Q1 FY26 | $0.05 | n/a | n/a | |
| Q3 FY25 | −$0.07 | −450% | n/a | |
| Q2 FY25 | −$0.10 | n/a | n/a | |
| Q1 FY25 | −$0.06 | n/a | n/a | |
| Q3 FY24 | $0.02 | n/a | n/a | |
| Q2 FY24 | −$0.12 | −167% | n/a | |
| Q1 FY24 | −$0.03 | n/a | n/a | |
| Q3 FY23 | −$0.02 | n/a | n/a | |
| Q2 FY23 | $0.18 | n/a | n/a | |
| Q1 FY23 | −$0.10 | n/a | n/a | |
| Q3 FY22 | −$0.12 | n/a | −$0.35 |
Against its peers
Companies in Drug Manufacturers - General nearest Eton Pharmaceuticals' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ETONEton Pharmaceuticals | n/m | |
| PCRXPacira BioSciences | $0.35 | |
| ANABAnaptysbio | $4.57 | |
| PAHCPhibro Animal Health | $2.44 | +107% a year |
| ANIPANI Pharmaceuticals | $4.70 | |
| OMEROmeros | $1.52 | |
| AMPHAmphastar Pharmaceuticals | $1.70 | −36% a year |
| HRMYHarmony Biosciences | $3.09 | −0% a year |
| PBHPrestige Consumer Healthcare | $3.57 | −16% a year |
| ABUSArbutus Biopharma | $0.78 | |
| COLLCollegium Pharmaceutical | $1.24 | +19% a year |
| Peer median | $2.07 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Eton Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.